These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 12019839)
21. Safety and efficacy of a novel hepatobiliary MR contrast agent GN-1140 (Gd-DTPA-DeA): from the results of phase I and phase II clinical trials. Tanimoto A; Kadoya M; Kawamura Y; Kuwatsuru R; Gokan T; Hirohashi S Acad Radiol; 2002 Aug; 9 Suppl 2():S457-9. PubMed ID: 12188307 [No Abstract] [Full Text] [Related]
22. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer. Liu Y; Chen Z; Liu C; Yu D; Lu Z; Zhang N Biomaterials; 2011 Aug; 32(22):5167-76. PubMed ID: 21521627 [TBL] [Abstract][Full Text] [Related]
23. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathological significance of the peritumoral decreased uptake area of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in hepatocellular carcinoma. Nishie A; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Ushijima Y; Takayama Y; Shirabe K; Fujita N; Kubo Y; Hirakawa M; Honda H J Gastroenterol Hepatol; 2014 Mar; 29(3):561-7. PubMed ID: 24219648 [TBL] [Abstract][Full Text] [Related]
25. Basic analysis of dynamic study in cases of hepatocellular carcinoma using inversion recovery snap shot FLASH MR imaging with Gd-DTPA. Suto Y; Kamba M; Kato T; Ohta Y Radiat Med; 1995; 13(2):89-94. PubMed ID: 7667515 [TBL] [Abstract][Full Text] [Related]
26. Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging. Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Huebner F; Zeuzem S; Korf HW; Vogl TJ; Rittmeyer C; Terfort A; Piiper A; Gelperina S; Kreuter J Eur J Pharm Biopharm; 2014 May; 87(1):132-41. PubMed ID: 24365328 [TBL] [Abstract][Full Text] [Related]
27. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA]. Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558 [TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751 [TBL] [Abstract][Full Text] [Related]
29. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography. Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939 [TBL] [Abstract][Full Text] [Related]
31. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis. Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909 [TBL] [Abstract][Full Text] [Related]
32. Double contrast MR imaging of hepatocellular carcinoma evaluating lesion detection and conspicuity. Akinci D; Oto A; Besim A; Akhan O; Abbasoglu O; Batman F; Eryilmaz M Acad Radiol; 2002 Aug; 9 Suppl 2():S466-7. PubMed ID: 12188310 [No Abstract] [Full Text] [Related]
33. [A case of hepatocellular carcinoma which could be diagnosed with Gd-EOB-DTPA enhanced MRI]. Ota H; Mikami K; Nagase A; Nagase H; Mukai R; Okada K; Ide Y; Maruyama K; Murata K; Yokouchi H; Tamai M; Kinuta M Gan To Kagaku Ryoho; 2009 Nov; 36(12):2386-8. PubMed ID: 20037431 [TBL] [Abstract][Full Text] [Related]
34. Primovist, Eovist: what to expect? Van Beers BE; Pastor CM; Hussain HK J Hepatol; 2012 Aug; 57(2):421-9. PubMed ID: 22504332 [TBL] [Abstract][Full Text] [Related]
35. The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI. Yim H; Yang SG; Jeon YS; Park IS; Kim M; Lee DH; Bae YH; Na K Biomaterials; 2011 Aug; 32(22):5187-94. PubMed ID: 21561660 [TBL] [Abstract][Full Text] [Related]
36. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images. Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258 [TBL] [Abstract][Full Text] [Related]
37. Incidental focal hepatic mass. Kim YC; Kim JK; Lee JH Br J Radiol; 2013 Jan; 86(1021):20110659. PubMed ID: 23239688 [No Abstract] [Full Text] [Related]
38. Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease. Motosugi U; Ichikawa T; Sano K; Sou H; Onohara K; Muhi A; Kitamura T; Amemiya F; Enomoto N; Matsuda M; Asakawa M; Fujii H; Araki T Invest Radiol; 2011 Feb; 46(2):141-5. PubMed ID: 21139506 [TBL] [Abstract][Full Text] [Related]